共 50 条
Targeting EBV-positive B- and T/NK-cell lymphomas
被引:3
|作者:
Long, Heather M.
[1
]
机构:
[1] Univ Birmingham, Birmingham, W Midlands, England
来源:
关键词:
PD-L1;
D O I:
10.1182/blood-2018-10-878587
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
In this issue of Blood, McLaughlin et al demonstrate the safety and efficacy of donor-derived Epstein-Barr virus (EBV) latent membrane protein (LMP)-specific T cells to prevent relapse of aggressive EBV-positive B- or T/NK-cell lymphomas following allogeneic hematopoietic stem cell transplantation (HSCT).(1)
引用
收藏
页码:2315 / 2316
页数:2
相关论文